Supplementary MaterialsTable_1. A (IgA), IgG and IgM, and risk of developing

Supplementary MaterialsTable_1. A (IgA), IgG and IgM, and risk of developing melanoma in the Swedish Apolipoprotein-related MORtality RISk (AMORIS) study. Methods: Study participants aged Apremilast cell signaling 20 years with baseline measurements of IgG, IgA Apremilast cell signaling and IgM taken between 1985 and 1996 were selected (= 29,876). All individuals were free from melanoma… Continue reading Supplementary MaterialsTable_1. A (IgA), IgG and IgM, and risk of developing